MGC Pharmaceuticals Limited
MGC Pharmaceuticals Limited MXC.L Peers
See (MXC.L) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MXC.L | £21.20 | -3.64% | 9.3M | -0.13 | -£1.66 | N/A |
| HLN.L | £413.90 | -0.31% | 37.3B | 25.87 | £0.16 | +0.02% |
| HIK.L | £2,140.00 | +0.47% | 4.7B | 17.98 | £1.19 | +2.50% |
| HCM.L | £207.00 | +0.49% | 1.8B | 69.00 | £0.03 | N/A |
| 0IRF.IL | £7.00 | +3.90% | 1.2B | -12.07 | -£0.58 | N/A |
| INDV.L | £944.50 | +4.02% | 1.2B | -236.12 | -£0.04 | N/A |
| APH.L | £64.70 | +0.02% | 349.7M | -32.35 | -£0.02 | N/A |
| AGY.L | £7.10 | +2.90% | 338.4M | -7.10 | -£0.01 | N/A |
| ANCR.L | £280.00 | -2.10% | 193.2M | 35.00 | £0.08 | +1.79% |
| BMK.L | £24.00 | -0.83% | 178M | -4.00 | -£0.06 | N/A |
Stock Comparison
MXC.L vs HLN.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, HLN.L has a market cap of 37.3B. Regarding current trading prices, MXC.L is priced at £21.20, while HLN.L trades at £413.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas HLN.L's P/E ratio is 25.87. In terms of profitability, MXC.L's ROE is +26.60%, compared to HLN.L's ROE of +0.09%. Regarding short-term risk, MXC.L is more volatile compared to HLN.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs HIK.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, HIK.L has a market cap of 4.7B. Regarding current trading prices, MXC.L is priced at £21.20, while HIK.L trades at £2,140.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas HIK.L's P/E ratio is 17.98. In terms of profitability, MXC.L's ROE is +26.60%, compared to HIK.L's ROE of +0.16%. Regarding short-term risk, MXC.L is more volatile compared to HIK.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs HCM.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, HCM.L has a market cap of 1.8B. Regarding current trading prices, MXC.L is priced at £21.20, while HCM.L trades at £207.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas HCM.L's P/E ratio is 69.00. In terms of profitability, MXC.L's ROE is +26.60%, compared to HCM.L's ROE of -0.01%. Regarding short-term risk, MXC.L is more volatile compared to HCM.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs 0IRF.IL Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, 0IRF.IL has a market cap of 1.2B. Regarding current trading prices, MXC.L is priced at £21.20, while 0IRF.IL trades at £7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas 0IRF.IL's P/E ratio is -12.07. In terms of profitability, MXC.L's ROE is +26.60%, compared to 0IRF.IL's ROE of -0.22%. Regarding short-term risk, MXC.L is more volatile compared to 0IRF.IL. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs INDV.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, INDV.L has a market cap of 1.2B. Regarding current trading prices, MXC.L is priced at £21.20, while INDV.L trades at £944.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas INDV.L's P/E ratio is -236.12. In terms of profitability, MXC.L's ROE is +26.60%, compared to INDV.L's ROE of -0.01%. Regarding short-term risk, MXC.L is more volatile compared to INDV.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs APH.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, APH.L has a market cap of 349.7M. Regarding current trading prices, MXC.L is priced at £21.20, while APH.L trades at £64.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas APH.L's P/E ratio is -32.35. In terms of profitability, MXC.L's ROE is +26.60%, compared to APH.L's ROE of -0.05%. Regarding short-term risk, MXC.L is more volatile compared to APH.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs AGY.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, AGY.L has a market cap of 338.4M. Regarding current trading prices, MXC.L is priced at £21.20, while AGY.L trades at £7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas AGY.L's P/E ratio is -7.10. In terms of profitability, MXC.L's ROE is +26.60%, compared to AGY.L's ROE of +20.72%. Regarding short-term risk, MXC.L is less volatile compared to AGY.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs ANCR.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, ANCR.L has a market cap of 193.2M. Regarding current trading prices, MXC.L is priced at £21.20, while ANCR.L trades at £280.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas ANCR.L's P/E ratio is 35.00. In terms of profitability, MXC.L's ROE is +26.60%, compared to ANCR.L's ROE of +0.31%. Regarding short-term risk, MXC.L is more volatile compared to ANCR.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs BMK.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, BMK.L has a market cap of 178M. Regarding current trading prices, MXC.L is priced at £21.20, while BMK.L trades at £24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas BMK.L's P/E ratio is -4.00. In terms of profitability, MXC.L's ROE is +26.60%, compared to BMK.L's ROE of -0.18%. Regarding short-term risk, MXC.L is more volatile compared to BMK.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs BXP.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, BXP.L has a market cap of 165.1M. Regarding current trading prices, MXC.L is priced at £21.20, while BXP.L trades at £37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas BXP.L's P/E ratio is 4.11. In terms of profitability, MXC.L's ROE is +26.60%, compared to BXP.L's ROE of +0.13%. Regarding short-term risk, MXC.L is more volatile compared to BXP.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs 0W1Q.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, 0W1Q.L has a market cap of 104.4M. Regarding current trading prices, MXC.L is priced at £21.20, while 0W1Q.L trades at £18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas 0W1Q.L's P/E ratio is -8.84. In terms of profitability, MXC.L's ROE is +26.60%, compared to 0W1Q.L's ROE of +0.41%. Regarding short-term risk, MXC.L is less volatile compared to 0W1Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs VLG.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, VLG.L has a market cap of 68.5M. Regarding current trading prices, MXC.L is priced at £21.20, while VLG.L trades at £53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas VLG.L's P/E ratio is 53.50. In terms of profitability, MXC.L's ROE is +26.60%, compared to VLG.L's ROE of +0.01%. Regarding short-term risk, MXC.L is more volatile compared to VLG.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs EAH.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, EAH.L has a market cap of 41.3M. Regarding current trading prices, MXC.L is priced at £21.20, while EAH.L trades at £61.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas EAH.L's P/E ratio is 61.00. In terms of profitability, MXC.L's ROE is +26.60%, compared to EAH.L's ROE of +0.01%. Regarding short-term risk, MXC.L is more volatile compared to EAH.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs STX.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, STX.L has a market cap of 25M. Regarding current trading prices, MXC.L is priced at £21.20, while STX.L trades at £2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas STX.L's P/E ratio is -1.20. In terms of profitability, MXC.L's ROE is +26.60%, compared to STX.L's ROE of +68.33%. Regarding short-term risk, MXC.L is less volatile compared to STX.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs PXS.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, PXS.L has a market cap of 11.7M. Regarding current trading prices, MXC.L is priced at £21.20, while PXS.L trades at £0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas PXS.L's P/E ratio is N/A. In terms of profitability, MXC.L's ROE is +26.60%, compared to PXS.L's ROE of -0.59%. Regarding short-term risk, MXC.L is less volatile compared to PXS.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs CHLL.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, CHLL.L has a market cap of 10.9M. Regarding current trading prices, MXC.L is priced at £21.20, while CHLL.L trades at £2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas CHLL.L's P/E ratio is -2.15. In terms of profitability, MXC.L's ROE is +26.60%, compared to CHLL.L's ROE of -3.55%. Regarding short-term risk, MXC.L is more volatile compared to CHLL.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs RGT.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, RGT.L has a market cap of 4.2M. Regarding current trading prices, MXC.L is priced at £21.20, while RGT.L trades at £6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas RGT.L's P/E ratio is -0.26. In terms of profitability, MXC.L's ROE is +26.60%, compared to RGT.L's ROE of +4.20%. Regarding short-term risk, MXC.L is less volatile compared to RGT.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs N4P.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, N4P.L has a market cap of 4M. Regarding current trading prices, MXC.L is priced at £21.20, while N4P.L trades at £0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas N4P.L's P/E ratio is -0.47. In terms of profitability, MXC.L's ROE is +26.60%, compared to N4P.L's ROE of -0.91%. Regarding short-term risk, MXC.L is less volatile compared to N4P.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs CEL.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, CEL.L has a market cap of 3.4M. Regarding current trading prices, MXC.L is priced at £21.20, while CEL.L trades at £5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas CEL.L's P/E ratio is -0.62. In terms of profitability, MXC.L's ROE is +26.60%, compared to CEL.L's ROE of -1.43%. Regarding short-term risk, MXC.L is less volatile compared to CEL.L. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs HELD.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, HELD.L has a market cap of 1.4M. Regarding current trading prices, MXC.L is priced at £21.20, while HELD.L trades at £0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas HELD.L's P/E ratio is N/A. In terms of profitability, MXC.L's ROE is +26.60%, compared to HELD.L's ROE of -3.64%. Regarding short-term risk, MXC.L is more volatile compared to HELD.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs 0A4X.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, 0A4X.L has a market cap of 10. Regarding current trading prices, MXC.L is priced at £21.20, while 0A4X.L trades at £0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas 0A4X.L's P/E ratio is -0.00. In terms of profitability, MXC.L's ROE is +26.60%, compared to 0A4X.L's ROE of N/A. Regarding short-term risk, MXC.L is more volatile compared to 0A4X.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs AMYT.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, AMYT.L has a market cap of 0. Regarding current trading prices, MXC.L is priced at £21.20, while AMYT.L trades at £143.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas AMYT.L's P/E ratio is -0.04. In terms of profitability, MXC.L's ROE is +26.60%, compared to AMYT.L's ROE of -1.07%. Regarding short-term risk, MXC.L is more volatile compared to AMYT.L. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.L.
MXC.L vs DNL.L Comparison
MXC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.L stands at 9.3M. In comparison, DNL.L has a market cap of 0. Regarding current trading prices, MXC.L is priced at £21.20, while DNL.L trades at £27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.L currently has a P/E ratio of -0.13, whereas DNL.L's P/E ratio is -0.03. In terms of profitability, MXC.L's ROE is +26.60%, compared to DNL.L's ROE of -0.59%. Regarding short-term risk, Volatility data is not available for a full comparison. MXC.L has daily volatility of 8.18 and DNL.L has daily volatility of N/A.